Custom Health Shows Promise in Chronic Pain Management Program
News related to:Custom Health Holdings Inc · 2 min read
Custom Health, an AI-enabled healthcare technology company, has announced early results from its ongoing commercial program with BKC Pain Specialists & Regenerative Medicine Clinic in Ohio, highlighting the potential of its integrated model for chronic pain management.
The program, which connects pharmacy services, in-home medication technology, and pharmacist-led clinical support, has demonstrated significant improvements in patient medication adherence and engagement. According to Custom Health, participating BKC patients have achieved approximately 94% medication adherence, with more than 7,400 patient survey responses captured through the company's connected platform.
The program provides continuous visibility into patients' medication use and experiences between physician visits, enabling personalized patient engagement and more coordinated care. BKC Pain Specialists & Regenerative Medicine Clinic, an Ohio-based specialty medical practice, is using Custom Health's technology to manage the complex medication regimens of its patients, who on average take 6.6 medications.
The Custom Health-BKC program seeks to address the gaps in traditional care by connecting in-home medication technology with pharmacy services and pharmacist-led clinical support. Through AdhereNet®, medication-taking activity and patient-reported information are made available to Custom Health's clinical team, helping pharmacists identify potential concerns, engage patients, and coordinate follow-up with BKC's physicians.
Early program data from an initial patient population demonstrates the depth of medication management and patient engagement enabled by the model. Based on internal Company data for the period from April 1, 2026, to present, patients achieved approximately 94% medication adherence, with more than 7,400 patient survey responses captured through the Company's connected platform.
The Custom Health-BKC program seeks to address these gaps by connecting in-home medication technology with pharmacy services and pharmacist-led clinical support. Through AdhereNet®, medication-taking activity and patient-reported information are made available to Custom Health's clinical team, helping pharmacists identify potential concerns, engage patients, and coordinate follow-up with BKC's physicians.
The collaboration demonstrates Custom Health's ability to integrate pharmacy infrastructure, connected medication technology, and pharmacist-led clinical support into existing specialty care workflows. Encouraging early results are supporting plans to expand the program across BKC's broader patient population, while demonstrating the potential to replicate this model across additional pain management practices and other specialty providers in the U.S.
Custom Health intends to continue expanding the program with BKC, building on encouraging early results and evaluating its impact on medication adherence, patient engagement, clinical workflows, and patient outcomes.